Genilume is a preclinical-stage therapeutics company using generative AI and a systems biology-centered approach to design innovative precision therapeutics.
Genilume was founded by a team of scientists and entrepreneurs who sought to revolutionize precision medicine and the treatment of complex diseases like cancer. Uniting shared passions for healthcare and innovation with a commitment to excellence, Genilume was built on a foundation of strong core values and a vision for a new era of healthcare.